Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

NCT00820560 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors and Hematologic Malignancy

Interventions

DRUG: INCB007839

Sponsor

Incyte Corporation